related content
Overpriced drugs developed with tax money
Research shows major Dutch public investment in drug development Overpriced, a report published today jointly by SOMO and Wemos examines the extent of Dutch public funding of drug development, through donations, loans and/or investments. This…
Overpriced
Drugs Developed with Dutch Public Funding
Position on supplementary protection certificates for medicinal products
In this joint statement, several civil society organisations have expressed their major concerns about the role of supplementary protection certificates (SPCs) in the accessibility and price of medicines in the Netherlands and elsewhere in Europe….
Common call to improve access to medicine
In the run-up to the general debate on Medicines policy on Thursday June 21st 2018, eight organizations in the Netherlands jointly sent a letter to the Dutch Parliament to inform them abouth their position concerning…
Organisations call for greater social impact of the European Commission’s medical research and innovation investments
Together with 22 civil society organisations, SOMO calls on the European Commission to seize the opportunity during the preparation of the 9th Framework Programme The 9th Framework Programme is the follow up of the Horizon…
Ethical verification of clinical trials on medication must be more stringent
Roche intimidates clinical drug trial participant following report
Following the publication of a critical report by SOMO on clinical drug trials in Egypt, pharmaceutical company Roche made reprehensible efforts to have damaging information removed from the report. They placed one of the interviewed…
Dialogue and questions in response to report on clinical trials in Egypt
Industry-sponsored clinical drug trials in Egypt
Ethical questions in a challenging context
Embarking on a system change for clinical trials in 2013
In the last few years the pharmaceutical team at SOMO has placed the emphasis on research and lobbying to protect the rights of test subjects in clinical trials. “In 2013 we will continue to be…
Share this